Search results
Dupixent set for FDA review in adolescent chronic inflammatory sinus disease
Pharmaceutical Technology via Yahoo Finance· 10 hours agoMany patients also have other type 2 inflammatory diseases such as asthma. Dupixent was first...
Eczema: New vaccine may help treat children with skin condition
Medical News Today· 6 days agoResearchers in Ireland say a new vaccine may help treat eczema flares in children. A...
...Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients During Virtual...
Benzinga· 7 days agoThe KOL event, "Treatment Options for Atopic Dermatitis Patients with an Inadequate Response to Dupilumab: Exploring the Potential of ...
East Bay biotech raises $105 million, aims to enter clinical trials with eczema drug - San Francisco...
The Business Journals· 3 days agoAttovia Therapeutics said the funding was led by Goldman Sachs Alternatives and included participation from new and existing investors. The new cash will be used to take Attovia's first drug ...
13 Penny Stocks with Insider Buying in 2024
Insider Monkey via Yahoo Finance· 1 day agoIn this article, we will take a detailed look at the 13 Penny Stocks with Insider Buying in 2024. If you want to skip our detailed analysis and see the...
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with...
Benzinga· 20 hours agoFood and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for Dupixent® (dupilumab) as an add-on maintenance treatment ...
Kids With Skin Diseases Face Stigma, Reduced Quality of Life
Medscape· 20 hours agoMost children with chronic skin diseases — such as acne, alopecia, eczema, psoriasis, and vitiligo —...
Q1 2024 Corvus Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 7 days agoThe trial was designed to enroll 64 patients with moderate to severe atopic dermatitis that have progressed on at least one prior therapy study is randomized ...
